LENVAGIST - A Multicenter, Comparative, Placebo-Controlled, Double-Blinded, Phase II Study of the Efficacy of Lenvatinib in Patients with Locally Advanced or Metastatic GIST after Failure of Imatinib and Sunitinib.
Journal of clinical oncology（2020）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined